Modification in prescribing practices for third-generation cephalosporins and ciprofloxacin is associated with a reduction in meticillin-resistant Staphylococcus aureus bacteraemia rate

Journal of Hospital Infection

Volumn 69, Issue 4, 2008, Pages 328-336

  Liebowitz, L D ^a   Blunt, M C ^a  

^a Queen Elizabeth Hospital King's Lynn NHS Trust   (United Kingdom)

Author keywords

Antibacterial agents; Cephalosporins; Education; Fluoroquinolones; Meticillin resistant Staphylococcus aureus; Quality improvement

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN;

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BLOOD CULTURE; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RATE; INTENSIVE CARE UNIT; INTERVENTION STUDY; MEDICAL EDUCATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; PRESCRIPTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CEPHALOSPORINS; CIPROFLOXACIN; HOSPITALS; HUMANS; METHICILLIN RESISTANCE; ORGANIZATIONAL POLICY; PRESCRIPTIONS, DRUG; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 47749106029     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2008.04.026     Document Type: Article

References (15)

1. LeBlanc L., Pepin J., Toulouse K., et al. Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 12 (2006) 1398-1405
2. Paterson D.L. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 38 Suppl. 4 (2004) S341-S345
3. Charbonneau P., Parienti J.J., Thibon P., et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis 42 (2006) 778-784
4. Madaras-Kelly K.J., Remington R.E., Lewis P.G., and Stevens D.L. Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 27 (2006) 155-169
5. Stone S.P., Beric V., Quick A., Balestrini A.A., and Kibbler C.C. The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphyloccocus aureus colonization in acute elderly medical patients. Age Ageing 27 (1998) 561-568
6. LeDell K., Muto C.A., Jarvis W.R., and Farr B.M. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24 (2003) 639-641
7. Office of National Statistics. Census 2001: key statistics for health areas in England and Wales (2003), Stationery Office, Norwich
8. Wagner A.K., Soumerai S.B., Zhang F., and Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27 (2002) 299-309
9. Gilbert D.N., Kohlhepp S.J., Slama A., et al. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin. Antimicrob Agents Chemother 45 (2001) 883-892
10. Evans M.E., and Titlow W.B. Levofloxacin selects fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus less frequently than ciprofloxacin. J Antimicrob Chemother 41 (1998) 285-288
11. Harris A.D., Lautenbach E., and Perencevich E. A systemic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis 41 (2005) 77-82
12. Pratt R.J., Pellowe C.M., Wilson J.A., et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 65 Suppl. 1 (2007) S1-S64
13. Nijssen S., Bootsma M., and Bonten M. Potential confounding in evaluating infection-control interventions in hospital settings: changing antibiotic prescription. Clin Infect Dis 43 (2006) 616-623
14. Weber S.G., Gold H.S., Hooper D.C., Karchmer A.W., and Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 9 (2003) 1415-1422
15. Bonten M.J., Austin D.J., and Lipsitch M. Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clin Infect Dis 33 (2001) 1739-1745